Ibustar (Ibuprofen)

Ibuprofen exerts its effect by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are required for the conversion of arachidonic acid to prostaglandins. By decreasing prostaglandin synthesis, it reduces the sensitisation of nerve endings to pain, lowers the hypothalamic set‑point for temperature, and diminishes inflammatory swelling.

The specific dose of Ibustar is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. The prescriber will select the appropriate strength, frequency, and duration in accordance with approved labeling and individual therapeutic needs.

The safety of ibuprofen during pregnancy and lactation depends on the trimester and clinical circumstances. Generally, ibuprofen is avoided in the third trimester because of potential fetal cardiovascular effects, and caution is advised during the first two trimesters. Breastfeeding mothers should consult a healthcare provider, as ibuprofen does pass into milk in small amounts.

To place an order, visit the product page on gnhindia.com, submit an enquiry with the required quantity, and provide institutional or trade credentials. GNH India’s commercial team will verify the information, then respond with pricing, availability, shipping terms (including any cold‑chain requirements if applicable), and necessary import documentation.

Ibustar’s active ingredient, ibuprofen, shares the same class mechanism as other non‑selective NSAIDs such as naproxen or diclofenac. Compared with some alternatives, ibuprofen has a relatively short half‑life, which may allow flexible dosing but may also require more frequent administration for sustained effect. Its safety profile is well‑characterised, though individual tolerability varies.

Ibustar tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister or bottle to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Ibustar is taken orally, with or without food, as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush or chew unless the formulation specifically permits it. The dosing interval and total daily dose are individualized by the healthcare professional.

The most serious adverse events linked to ibuprofen include gastrointestinal bleeding or ulceration, severe renal impairment, and hypersensitivity reactions such as anaphylaxis. Patients with a history of ulcer disease, cardiovascular disorders, or kidney dysfunction should be monitored closely, and any signs of serious bleeding or allergic reaction require immediate medical attention.

Ibustar is contraindicated in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulceration or bleeding, and patients with severe heart failure or advanced renal disease. It should also be avoided in the third trimester of pregnancy and in patients receiving certain anticoagulants without careful risk assessment.